Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

A thought experiment in prevention: What if dogs do more for cardiovascular health than statins? Let’s examine the data, ...

Randomized controlled trials provide ‘weak support’ for the idea that ultraprocessed foods are ‘inherently harmful’ simply ...

We need more empirical studies about the impact of generative AI on our mental health. I dissect one recent study to show counterintuitive results. An AI Insider scoop.

This is part one of a two-part article offering proposals to improve the FDA’s guidance to implement a new approval framework ...

GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not ...

The findings from two clinical trials suggest that a lower dose of GLP-1 drugs, or switching to an oral pill like Foundayo, can help to maintain weight loss.

Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 11:20 AM EDTCompany ParticipantsLynn Seely ...

Thanks for your interest in UCB and BIMZELX, a key growth driver for UCB. So I'm Head of Patient Impact, as Yvonne mentioned. Essentially, in other companies, this would be called development and ...

Initial data from ongoing Phase 1/2 trial in patients with second and third line PDAC treated with vopimetostat and daraxonrasib showed 6-month ...

Glucosamine tied to faster progression in people with established neurodegeneration ...

One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic ...